Key result
T-cell MyD88 deletion increases cardiac T-cell infiltration and fibrosis after TAC versus wild type.
Why the study?
The role of MyD88 in T-cell activation and cardiac inflammation during heart failure was unknown.
MyD88 plays a novel intrinsic role in limiting T-cell activation, which is central to tuning down cardiac inflammation and fibrosis during cardiac adaptation to stress.
T-cell MyD88 may protect against fibrosis in cardiac stress; leaves open its role as therapeutic target in human heart failure.
BACKGROUND: Cardiac inflammation in heart failure is characterized by the presence of damage-associated molecular patterns, myeloid cells, and T cells. Cardiac damage-associated molecular patterns provide continuous proinflammatory signals to myeloid cells through TLRs (toll-like receptors) that converge onto the adaptor protein MyD88 (myeloid differentiation response 88). These induce activation into efficient antigen-presenting cells that activate T cells through their TCR (T-cell receptor). T-cell activation results in cardiotropism, cardiac fibroblast transformation, and maladaptive cardiac remodeling. T cells rely on TCR signaling for effector function and survival, and while they express MyD88 and damage-associated molecular pattern receptors, their role in T-cell activation and cardiac inflammation is unknown. METHODS: We performed transverse aortic constriction in mice lacking MyD88 in T cells and analyzed remodeling, systolic function, survival, and T-cell activation. We profiled wild type versus Myd88 −/− mouse T cells at the transcript and protein level and performed several functional assays. RESULTS: Analysis of single-cell RNA-sequencing data sets revealed that MyD88 is expressed in mouse and human cardiac T cells. MyD88 deletion in T cells resulted in increased levels of cardiac T-cell infiltration and fibrosis in response to transverse aortic constriction. We discovered that TCR-activated Myd88 −/− T cells had increased proinflammatory signaling at the transcript and protein level compared with wild type, resulting in increased T-cell effector functions such as adhesion, migration across endothelial cells, and activation of cardiac fibroblast. Mechanistically, we found that MyD88 modulates T-cell activation and survival through TCR-dependent rather than TLR-dependent signaling. CONCLUSIONS: Our results outline a novel intrinsic role for MyD88 in limiting T-cell activation that is central to tune down cardiac inflammation during cardiac adaptation to stress.
No takes yet. Share an insight, caveat, or question.
Bayer et al. (2023) studied Cardiac inflammation and fibrosis. MyD88 deletion in T cells vs. Wild type was evaluated on Cardiac T-cell infiltration and fibrosis. MyD88 deletion in T cells resulted in increased levels of cardiac T-cell infiltration and fibrosis in response to transverse aortic constriction compared with wild type.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: